BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Statera Biopharma, Inc. to Report Third Quarter 2021 Financial ResultsManagement to Host Conference Call on Monday, November 15, 2021, at 5:30 p.m. ET

  Statera Biopharma, Inc. announced today that the Company will host a conference call and live audio webcast on Monday, November 15, 2021, at 5:30 p.m. ET, to discuss its corporate and financial results for the third quarter of 2021.

  November 9, 2021

   · 

  5 min read
• Business

  Acerus Reports Fiscal Third Quarter 2021 Financial Results

  Acerus Pharmaceuticals Corporation reported its financial results for the three and nine-month period ended September 30, 2021.

  November 9, 2021

   · 

  15 min read
• Business

  Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update

  Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update

  November 9, 2021

   · 

  14 min read
• Genetown

  Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322, a New Potential Restorative Treatment for Hearing Loss and In Vivo Data for Its Remyelination Program in Multiple Sclerosis

  Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322

  November 9, 2021

   · 

  9 min read
• Bio NC

  9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference

  9 Meters Biopharma, Inc. today announced that the Company’s CEO, John Temperato is scheduled to present at the 12th Annual Jefferies London Healthcare Conference

  November 9, 2021

   · 

  3 min read
• Genetown

  Allurion Technologies Announces New Data on the Impact of the Allurion Program on Type 2 Diabetes and Prediabetes

  Allurion Technologies today announced new clinical data on the Allurion Program presented at ObesityWeek® 2021.

  November 9, 2021

   · 

  3 min read
• Business

  Neuronetics Reports Third Quarter 2021 Financial and Operating Results

  Neuronetics, Inc. today announced its financial and operating results for the third quarter of 2021.

  November 9, 2021

   · 

  15 min read
• Business

  Delcath Systems Announces Third Quarter 2021 Results

  Delcath Systems, Inc., an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, reported business highlights and financial results for the third quarter ended September 30, 2021.

  November 9, 2021

   · 

  12 min read
• Business

  Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates

  Harmony Biosciences Reports Third Quarter 2021 Financial Results and Business Updates

  November 9, 2021

   · 

  17 min read
• Bio NC

  Dentsply Sirona to Present at Upcoming Virtual Investor Conferences

  DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) - announced today that the Company will present at three upcoming investor conferences.

  November 9, 2021

   · 

  1 min read